William Hagopian
Endocrinology, Diabetes & Metabolism · Seattle, WANPI 1841380706
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,201 of the $30,055 with a category attached, or 90.5%. Sanofi accounts for 64.1% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $19,279, more than ten times the $711 reported in 2019. Among endocrinology, diabetes & metabolism clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $1669.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$19K
- Sanofi-aventis U.S. LLC$10K
- Novo Nordisk$690
- Janssen Research & Development, LLC$64
- Novo Nordisk US Research & Development, Inc.$21
Across 20 payments — averaging $101,007 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$2M
- Novo Nordisk AS$15K
What the payments were for
- Consulting fees$27,20191%
- Travel & lodging$1,9116%
- Food & beverage$9433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 4 | $19,279 |
| Sanofi-aventis U.S. LLC | 11 | $10,001 |
| Novo Nordisk | 1 | $690 |
| Janssen Research & Development, LLC | 1 | $64 |
| Novo Nordisk US Research & Development, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$6,314
- SOLIQUA 100/33$3,545
How this compares
$30,055 in reported general payments places this provider in the 90th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.
See all endocrinology, diabetes & metabolism providers in Washington →
Other endocrinology, diabetes & metabolism in Seattle
- Irl HirschSeattle$192K
- Nicole EhrhardtSeattle$111K
- Kristina UtzschneiderSeattle$72K
- Savitha SubramanianSeattle$71K
- Mahnaz MellatiSeattle$28K
- Alan ChaitSeattle$21K
- Jose GarciaSeattle$12K
- Carla GreenbaumSeattle$7K
- Tracy TyleeSeattle$7K
- Asha PathakSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.